| Melanocytic Neoplasm studied in …STUDIED_INderived200 of 3,258show all (up to 200) |
|---|
| → studied in | NCT00003641Phase 3 · completed High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708418Phase 2 · active not recruiting A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma · condition mapped PROBABILISTIC · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466434NA · recruiting Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005297not yet recruiting Clinical Genetics Branch Eligibility Screening Survey · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224425Phase 1 · recruiting A Study of BI 3810944 in Patients With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281924Phase 1/Phase 2 · recruiting Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328516enrolling by invitation Natural History Study of Early Life Exposures in Agriculture (ELEA) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847359Phase 2 · recruiting Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07848243Phase 2 · recruiting Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040352recruiting Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068003enrolling by invitation Harvesting Cells for Experimental Cancer Treatments · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05196087recruiting Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06961006Phase 2 · recruiting A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07519655Phase 1 · recruiting Phase 1 Study of PF-08046033 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702309recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246916Phase 3 · recruiting A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548789Phase 2 · recruiting Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476326Phase 1 · recruiting Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841925Phase 1/Phase 2 · not yet recruiting A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05727904Phase 3 · recruiting Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06828822NA · recruiting CongenItal Naevus Cohort for Longitudinal Evaluation · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Congenital Cutaneous Nevus | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07068074Phase 3 · recruiting Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621614Phase 2 · recruiting A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanocytic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838974Phase 1 · not yet recruiting Adding Anakinra and Tocilizumab to Nivolumab and Ipilimumab for the Treatment of Melanoma Patients 50 Years of Age or Older · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03340506Phase 4 · recruiting Dabrafenib and/or Trametinib Rollover Study · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044859Phase 1 · active not recruiting ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177937Phase 1 · recruiting A Study of DXC014 in Patients With Advanced Solid Tumors. · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339176Phase 1/Phase 2 · recruiting Intratumoral N17350 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661966NA · recruiting Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836712Phase 2 · not yet recruiting Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05629546Phase 1 · suspended Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913388Phase 2 · active not recruiting GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066138Phase 1 · recruiting A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04464759Phase 1/Phase 2 · active not recruiting A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05279027early Phase 1 · active not recruiting Zr89 + PET Companion Trial · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014086Phase 1 · completed Intratumoral PH-762 for Cutaneous Carcinoma · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529822Phase 1 · recruiting Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562841Phase 1 · recruiting Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830225NA · recruiting A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma. · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831083completed Skin Cancer Among Outdoor Workers · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04038619Phase 1 · recruiting Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752826Phase 1/Phase 2 · recruiting BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04990726active not recruiting Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05267626Phase 1/Phase 2 · recruiting Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863052active not recruiting Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398418Phase 1 · recruiting R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06906822Phase 2 · active not recruiting PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03054584recruiting Genetic Basis of Melanocytic Nevi · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Pigmented Nevus | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03605771active not recruiting Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04544748Phase 1 · completed A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05264974Phase 1 · suspended Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04741997early Phase 1 · recruiting Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05155033Phase 2 · recruiting Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05764395Phase 2 · terminated Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303341Phase 1 · active not recruiting Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196181Phase 2 · active not recruiting Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03804255withdrawn Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511013Phase 2 · recruiting A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05358938early Phase 1 · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524935Phase 2 · active not recruiting Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607095Phase 1 · recruiting A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06623461Phase 2 · recruiting LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07040280Phase 2 · recruiting Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Dysplastic Nevus | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057596Phase 2 · recruiting Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804186Phase 3 · recruiting Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819474NA · not yet recruiting Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820033Phase 2 · not yet recruiting Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134614Phase 2 · active not recruiting Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01720407Phase 3 · completed Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Lentigo Maligna Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01840527completed Utility of Novel BRAF Test for Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03149029Phase 2 · active not recruiting Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06101134Phase 2 · active not recruiting A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06500455Phase 3 · active not recruiting Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817901Phase 1/Phase 2 · not yet recruiting Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140500Phase 1/Phase 2 · active not recruiting Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04866810NA · suspended The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05470283Phase 1 · active not recruiting Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640193Phase 1 · active not recruiting A Study of LN-144 in People With Metastatic Melanoma to the Brain · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07527325Phase 2 · not yet recruiting Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815574Phase 3 · not yet recruiting iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815873NA · not yet recruiting Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01029873Phase 1/Phase 2 · terminated QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01364051Phase 1 · active not recruiting Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02678572Phase 3 · completed Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Ocular Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04796194Phase 2 · completed Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05546827Phase 2 · recruiting Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Sinonasal Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557045Phase 1 · active not recruiting A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665595Phase 3 · terminated A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691255recruiting MELanoma Brain Metastasis Treated With CYberknife · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01480154Phase 1 · active not recruiting Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04899908Phase 2 · recruiting Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903937Phase 1 · not yet recruiting Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06070012Phase 2 · recruiting Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183852Phase 1 · not yet recruiting Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288112Phase 1/Phase 2 · recruiting DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001823recruiting Evaluation for NCI Surgery Branch Clinical Research Protocols · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01274338Phase 3 · active not recruiting Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03122522Phase 2 · active not recruiting A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03897881Phase 2 · active not recruiting An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05061017Phase 2 · completed Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718243Phase 1/Phase 2 · recruiting Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807878Phase 2 · not yet recruiting Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808164recruiting ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03584334NA · completed 18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04013854Phase 2 · active not recruiting Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287917Phase 1/Phase 2 · recruiting Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657991Phase 3 · active not recruiting A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07400302Phase 2 · recruiting Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552597Phase 3 · not yet recruiting Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803562Phase 2 · not yet recruiting Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562129Phase 2 · active not recruiting IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04913285Phase 1 · recruiting A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05089370Phase 1/Phase 2 · active not recruiting Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05837767NA · recruiting A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06284590Phase 2 · recruiting Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02997553Phase 3 · completed Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03021460Phase 1 · completed Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305041Phase 1/Phase 2 · completed Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557956Phase 1/Phase 2 · active not recruiting Testing the Addition of the Anti-cancer Drug, Tazemetostat, to (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04866680NA · active not recruiting Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355701Phase 1 · active not recruiting A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538130Phase 1 · active not recruiting A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305247Phase 1/Phase 2 · active not recruiting A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796594NA · active not recruiting Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03743766Phase 2 · completed Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03948724NA · completed Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830058Phase 2 · recruiting Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896839Phase 1/Phase 2 · recruiting Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07076550Phase 1 · terminated A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma · condition mapped PROBABILISTIC · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07310784Phase 2 · recruiting A Phase II Trial of LM103 in Advanced Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07794501not yet recruiting Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923026enrolling by invitation Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02224781Phase 3 · active not recruiting Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339571Phase 2/Phase 3 · active not recruiting A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506153Phase 3 · active not recruiting Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06683755Phase 1/Phase 2 · recruiting Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03131908Phase 1/Phase 2 · completed Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04303169Phase 1/Phase 2 · completed Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318717Phase 2 · recruiting Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Head and Neck Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05779423Phase 2 · recruiting Cryoablation+Ipilimumab+Nivolumab in Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06739226Phase 1/Phase 2 · not yet recruiting Combination Immunotherapy Targeting Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053230NA · active not recruiting A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05625399Phase 3 · active not recruiting A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598137active not recruiting Study to Examine Lesions of the Skin Using Confocal Laser Microscopy · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349303Phase 2 · recruiting Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07720726Phase 4 · not yet recruiting Impact of Dysport on PMFF Donor Scar · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07788729NA · recruiting Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanocytic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06545682Phase 1 · recruiting Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02858921Phase 2 · active not recruiting Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034536Phase 2 · active not recruiting PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07193966Phase 1/Phase 2 · terminated NG2 and DLL3 CAR-T Cells Targeting Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07475572Phase 1 · recruiting Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504796Phase 2 · recruiting ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772771recruiting Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384417NA · completed Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549439NA · completed eFLASH for Skin Lesions of Malignant Melanomas · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524114recruiting Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01644591Phase 2 · active not recruiting Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02621021Phase 2 · recruiting A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04572451Phase 1 · active not recruiting Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649681NA · recruiting Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03454035Phase 1 · recruiting Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06298734NA · recruiting High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07115043Phase 1/Phase 2 · recruiting A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07338968enrolling by invitation A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma · condition mapped ALIAS · 3,258 trials mapped (760 active) | — | — | Choroid Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565285Phase 2 · recruiting The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636785Phase 1/Phase 2 · recruiting A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04598009Phase 2 · recruiting Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06743126Phase 3 · recruiting SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07160335Phase 1 · active not recruiting A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03646617Phase 2 · active not recruiting Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04370704Phase 1/Phase 2 · completed Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895709Phase 1/Phase 2 · recruiting A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463796recruiting InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Spitz Nevus | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146920NA · active not recruiting Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07102212NA · suspended Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) · condition mapped ONTOLOGY_EXACT · 3,258 trials mapped (760 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |